Nova Eye Medical Limited
ELXMF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $38 | $31 | $24 | $1 |
| - Cash | $5 | $6 | $7 | $8 |
| + Debt | $3 | $3 | $2 | $2 |
| Enterprise Value | $36 | $28 | $18 | -$5 |
| Revenue | $29 | $23 | $17 | $13 |
| % Growth | 25.5% | 37% | 27.3% | – |
| Gross Profit | $19 | $20 | $1 | -$1 |
| % Margin | 64.5% | 86.6% | 4.9% | -5.7% |
| EBITDA | -$7 | -$6 | -$9 | -$8 |
| % Margin | -23% | -25.6% | -55.7% | -59% |
| Net Income | -$9 | -$9 | -$15 | -$7 |
| % Margin | -31% | -37.7% | -89.8% | -56% |
| EPS Diluted | -0.037 | -0.043 | -0.096 | -0.051 |
| % Growth | 15.1% | 54.9% | -89.1% | – |
| Operating Cash Flow | -$6 | -$8 | -$7 | -$5 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$6 |
| Free Cash Flow | -$6 | -$8 | -$8 | -$10 |